Chlamydia trachomatis/Neisseria gonorrhoeae (TMA)
Use
The APTIMA Combo 2 Assay for Chlamydia trachomatis/Neisseria gonorrhoeae is an in vitro qualitative nucleic acid amplification test cleared by the FDA for the detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) in clinician collected specimens for screening of symptomatic and asymptomatic individuals for evidence of chlamydial and/or gonococcal urogenital disease.
Special Instructions
Not provided.
Limitations
Stated turn-around-times (TATs) are for clinical use only and subject to change based on biopharma protocol requirements. Final TATs will be specified in the biopharma study contract.
Methodology
PCR-based (TMA)
Biomarkers
Chlamydia trachomatis
MicroorganismNeisseria gonorrhoeae
Microorganism
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Cervical Swab
Volume
3mL
Minimum Volume
Not provided
Container
ThinPrep® or SurePath™
Storage Instructions
2°C to 25°C
Causes for Rejection
Insufficient specimen volume; No swab in transport tube; Urine specimens >24 hours old unless transferred to APTIMA urine transport (YELLOW) tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 21 Days |